0000899243-22-004869.txt : 20220204
0000899243-22-004869.hdr.sgml : 20220204
20220204175028
ACCESSION NUMBER: 0000899243-22-004869
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Day Steven J
CENTRAL INDEX KEY: 0001845281
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 22594895
MAIL ADDRESS:
STREET 1: 2344 BANYAN DRIVE
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-02
0
0001098972
AGENUS INC
AGEN
0001845281
O'Day Steven J
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
0
1
0
0
Chief Medical Officer
Common Stock
2022-02-02
4
A
0
101682
2.51
A
163003
D
Reflects the executive's 2021 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 6-month lockup restriction with 25% of the award released on the 3-month anniversary of the issuance date and 75% of the award released on the 6-month anniversary.
$2.51 was the fair market value of our Common Stock on February 2, 2022, the stock issuance date.
/s/ Steven J. O'Day
2022-02-04